...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Debt

,,yes,, I agree fouremm,,,,, I am just sour on our CEO/Company,,who/which flounders at everything he touches! If Zen is sold I will make this point that they will tie up the bulk of ROI where the cash will be under control of our so called Team and remain at arms length from us shareholders, if this idea is at all possible. I really believe the team hates their long time shareholders. The disrespect managment has shown us is record setting!,,I still cant understand these big name Pharmas which are in trial with Zen and still are not making attempts to take it out,,or partner with eachother to take it.....maybe if a sale comes to fruition the other company will go with it like DMcC gives out warrants to the new PP money!!!,,lmfao,,,you can tell he doesnt believe his own lies,,,,the PP levels support this idea. ,,all would not surprise me in the least,,,,the absolute bizarre handling of info and affairs is stunning!,,,,I do have hope ,,its just so dim it causes me heartburn every time I cross paths with my accounts and the missing connections everywhere!!

Share
New Message
Please login to post a reply